These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17206389)

  • 21. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid lowering and coronary risk.
    Gotto AM
    Isr J Med Sci; 1996 Jun; 32(6):355-9. PubMed ID: 8682640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotinic acid and other therapies for raising high-density lipoprotein.
    Carlson LA
    Curr Opin Cardiol; 2006 Jul; 21(4):336-44. PubMed ID: 16755203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Benefits of intensive reduction of low density lipoprotein cholesterol].
    Posadas Romero C
    Arch Cardiol Mex; 2003; 73 Suppl 1():S116-20. PubMed ID: 12966660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on lipid-lowering therapy and LDL-cholesterol targets.
    Wiviott SD; Cannon CP
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):424-36. PubMed ID: 16874355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk reduction strategies in coronary artery disease.
    Gibson TM; Ratts T
    J La State Med Soc; 2001 Jun; 153(6):312-9. PubMed ID: 11480382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
    Tamargo J; Caballero R; Gómez R; Núñez L; Vaquero M; Delpón E
    Pharmacol Ther; 2007 Apr; 114(1):107-26. PubMed ID: 17287023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statins in aortic stenosis].
    Dejanović J; Ivanov I
    Med Pregl; 2009; 62 Suppl 3():101-4. PubMed ID: 19702126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.
    Colatsky TJ
    Curr Opin Investig Drugs; 2009 Mar; 10(3):239-44. PubMed ID: 19333881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?
    Efthimiadis A
    Angiology; 2008; 59(2 Suppl):62S-4S. PubMed ID: 18628276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH
    Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of high-density lipoprotein cholesterol in atherothrombosis.
    Choi BG; Vilahur G; Viles-Gonzalez JF; Badimon JJ
    Mt Sinai J Med; 2006 Jul; 73(4):690-701. PubMed ID: 16878275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Statins and their influence on inflammatory processes in internal carotid artery stenosis].
    Kunte H; Amberger N; Rückert RI; Harms L
    Zentralbl Chir; 2007 Jun; 132(3):193-7. PubMed ID: 17610188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.